Pre_Xovatra PF Assessment April 2025

Travoprost Helps in ?

• 12-hour IOP control
• 24-hour IOP control
• 48-hour IOP control
• 6 hour IOP control
• B

Dosing regimen of Travoprost PGA ?

• once daily dosing
• Twice daily dosing
• Thrice daily dosing
• As per Need
• A

What is OSD Prevalence in Galucoma Patient ?

• 20 -40%
• 30-70%
• 40-60%
• 0.5
• B

Preservative conatining formulation affects?

• Corneal damage
• Conjunctival inflammatory cells
• Dry eyes
• All the above
• D

What are benefits of Preservative Free glaucoma ?

• Prevents ocular surface inflammation
• Better adherence
• Improves patients’ quality of life1
• All the above
• D

Brand to Target in travoprost Market ?

• Travisight
• Tovaxo
• Travatan
• Travo Z
• C

which of the following statements is TRUE regarding Travoprost’s selectivity and binding affinity?

• Travoprost has lower selectivity for FP receptors, leading to more side effects
• Travoprost has lower binding affinity and potency compared to other PGAs.
• Travoprost’s free acid binds to FP receptors 1.8 to 2.5 times better than latanoprost acid.
• Travoprost’s binding affinity is weaker than latanoprost acid at FP receptors.
• C

Which of the following is NOT listed as a prerequisite for an ideal glaucoma agent met by Travoprost?

• Consistently lowers IOP
• Controls IOP fluctuation
• Requires frequent dosing
• Safe & well tolerated
• C

How many Patient to Enroll with PSP per week

• 20
• 10
• 40
• 15
• C

How many P1 Drs are to be targeted for Xovatra PF

• 20
• 10
• 15
• 30
• A